A Scalable Tissue Culture Protocol Enables Genetic Improvements and Advanced Breeding Across to Improve Fruit Quality and Yield
This in vitro shoot regeneration protocol targets six southern highbush blueberries (SHB) to support the generation of new and improved cultivars. Blueberry is an important fruit cop with a unique flavor and nutritional value. The demand for blueberries is increasing worldwide, driven by several factors, including their high levels of vitamins, anthocyanins, and other bioactive compounds that have antioxidant, anti-tumor, and anti-inflammatory properties. The global blueberry market is expected to grow at a 6% compound yearly rate between 2025 and 2029, reaching around 12.38 billion US dollars by 2029.
The rising demand has led to an increased production of blueberries in both traditional and new growing areas around the world. Southern highbush blueberries play an important role in this expansion, as the variety combines the fruit quality and productivity of highbush blueberries with a low chilling requirement—essential for producing a crop in subtropical and tropical areas of the globe. While blueberry breeders have made significant efforts to develop improved cultivars using conventional breeding strategies. However, these strategies are time-consuming and labor-intensive, often taking up to 12 years to develop and release a new SHB cultivar.
Southern highbush blueberry improvement increasingly relies on advanced breeding tools such as genetic transformation and genome editing to accelerate trait development. However, the effectiveness of these approaches depends on the ability to regenerate whole plants from small tissue explants. In Southern highbush blueberry, regeneration is highly genotype dependent, and many elite commercial cultivars exhibit poor or inconsistent shoot regeneration using existing tissue culture protocols. This limitation constrains the application of modern biotechnology in blueberry breeding and slows the development of improved cultivars in the global blueberry industry continuing to expand in scale and production. There is a need to integrate modern precision breeding tools with conventional approaches to increase genetic gain per breeding cycle.
Researchers at the University of Florida have developed an in vitro regeneration and transformation platform for addressing the key technical bottleneck limiting blueberry improvement. Southern highbush blueberry varieties are genetically diverse and notoriously difficult to regenerate in vitro, making genetic transformation and advanced breeding approaches unreliable or cultivar-restricted. This platform enables consistent shoot regeneration across diverse genotypes, providing a reliable foundation for advanced breeding and biotechnology applications in commercially relevant blueberry cultivars.
Application
Shoot regeneration platform for supporting genetic transformation, gene editing, and advanced breeding of Southern highbush blueberry cultivars
Advantages
- Uses genotype-specific regeneration conditions, enabling reliable shoot regeneration across diverse Southern highbush blueberry cultivars
- Employs leaf-based explants and defined growth regulator combinations, increasing regeneration efficiency compared to non-optimized protocols
- Supports downstream genetic transformation workflows, enabling modern biotechnology approaches in elite commercial blueberry varieties
- Reduces regeneration failures common in blueberry tissue culture, improving reproducibility and scalability for breeding programs
Technology
University of Florida researchers have developed an in vitro shoot regeneration platform for Southern highbush blueberry based on cultivar-specific optimization of plant growth regulators in a defined tissue culture system. The platform uses leaf explants cultured on a basal medium supplemented with carefully selected cytokinin concentrations to induce efficient shoot formation. Regeneration performance was evaluated across multiple genetically distinct Southern highbush blueberry cultivars, demonstrating that regeneration success is highly genotype dependent and can be significantly improved through tailored hormone formulations.
The platform enables consistent shoot regeneration in cultivars that are traditionally difficult to regenerate, providing a practical foundation for Agrobacterium-mediated transformation and other genetic modification approaches. By overcoming regeneration limitations, this technology enables advanced breeding and functional genomics efforts in Southern highbush blueberry, supporting the development of improved cultivars aligned with market demand.
Brochure
